Xingchen Peng, Professor
West China Hospital · Department of Biotherapy, West China Hospital, Sichuan University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xingchen Peng, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07339774 · Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.West China Hospital · recruiting · Radiotherapy-induced Oral Mucositis · principal investigator
- Ph2NCT07040969 · Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck TumorsWest China Hospital · active not recruiting · Radiation-induced Oral Mucositis · principal investigator
- Ph1/Ph2NCT07035249 · DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid TumorsWest China Hospital · recruiting · DCSZ11, Solid Tumors, HNSCC · principal investigator
- Ph1NCT06878612 · a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid TumorsXingchen Peng · recruiting · Polyphenols, Cancer Vaccine, Advanced Solid Tumor · principal investigator
- Ph1NCT06494189 · Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous CarcinomaWest China Hospital · completed · Head and Neck Cancer · principal investigator
- Ph2NCT05659186 · PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWest China Hospital · unknown · Thyroid Cancer · principal investigator
- Ph2NCT05517330 · Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell CarcinomaWest China Hospital · completed · Head and Neck Cancer · principal investigator
- Ph2NCT05516589 · Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCCWest China Hospital · completed · Head and Neck Squamous Cell Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.